|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Multiple-dose pharmacokinetics,pharmacodynamics and safety of atorvastatin,an inhibitor of HMG-CoA reductase,in healthy subjects显示文摘 | Whitfield LR Gibson DM | 1996 | Clin Pharmacol Ther1996，60，6： | 1 |
| 2 | Pharmacodynamic effects and pharmacokinetics of atorvastatin after administration to normocholesterolemic subjects in the morning and evening显示文摘 | Gibson DM Whitfield LR | 1996 | Clin Pharmacol1996，36，7： | 1 |
| 3 | Effect of food on the pharmacodynamics and pharmacokinetics of atorvastatin,an inhibitor of HMG-CoA reductase显示文摘 | Stern RH Sedman AJ | 2000 | Eur J Drug Metab Pharmacokinet2000，25，2： | 1 |
| 4 | Atorvastatin transport in the Caco-2 cell model: contributions of p-Glycoprotein and the pro-tonmonocarboxylic acid cotransporter显示文摘 | Wu XC Whitfield LR Stewart BH | 2000 | Pharm Res2000，17，2： | 1 |
| 5 | Multiple-dose pharmacokinetics,pharmacodynamics,and safety of torvastatin,an inhibitor of HMG-CoA reductase,in healthy subjects显示文摘 | Cilla DD Jr Whitfield LR Gibson DM | 1996 | Clin Pharmacol Ther1996，60，6： | 1 |
| 6 | Mutiple-dose pharmacokinetics, pharmacodinamics, and safety of atorvastatin, an inhibitor of HMG-CoA reductase, in healthy subjects 显示文摘 | Cilla DD Whitfield LR Gibson DM | 1996 | J Clin Pharmacol1996，60，6： | 1 |
| 7 | Multiple-dose pharmacokinetics,pharmacodynamics,and safety of atorvastatin,an inhibitor of HMG-CoA reductase,in healthy subjects显示文摘 | Cilla DD Whitfield LR Gibson DM | 1996 | Clin Pharmacol Ther1996，60，： | 1 |
| 8 | Effect of food on the pharmacodynamics and pharmacokinetics of atorvastatin, an inhibitor of HMG-CoA reductase显示文摘 | WHITFIELD LR STERN RH SEDMAN AJ | 2000 | Eur J Drug Metab Pharmacokinet2000，25，2： | 1 |
| 9 | Atorvastatin transport in the Caco-2 cell model: contributions of Pglycoprotein and the protonmonocarboxylic acid cotransporter 显示文摘 | Wu XC Whitfield LR Stewart BH | 2000 | Pharm Res2000，17，2： | 1 |
| 10 | Atorvastatin transport in the Caco-2 cell model: contributions of P-glycoprotein and proton-monocarboxylic acid co-transporter显示文摘 | WU X WHITFIELD LR STEWART BH | 2000 | Pharm Res2000，17，2： | 1 |
| 11 | Atorvastatin transport in the Caco-2 cell model :contributions of p-Glycoprotein and the protonmonocarboxylic acid co-transporter显示文摘 | Wu XC Whitfield LR Stewart BH | 2000 | Pharm Res2000，17，2： | 1 |
| 12 | Atorvastatin transport in the Caco-2 ceil model:contributions of p-glycoprotein and the protonmonocarboxyiic acid cotransporter显示文摘 | Wu XC Whitfield LR Stewart BH | 2000 | Phap m Res2000，17，2： | 1 |
| 13 | Pharmacodynamic effects and pharmacokinetics of atorvastatin after administration to normocholesterolemic subjects in the morning and evening显示文摘 | Cilla DD Jr Gibson DM Whitfield LR Sedman AJ | 1996 | J Clin Pharmacol1996，36，： | 1 |
| 14 | Effect of gemfibrozil and fenofibrate on the pharmacokinetics of atorvastatin显示文摘 | Whitfield LR Porcari AR Alvey C | 2011 | J Clin Pharmacol2011，51，3： | 1 |
| 15 | Effect of food on the pharma- codynamics and pharmacokinetics of atorvastatin, an inhibitor of HMG- CoA reductase 显示文摘 | Whitfield LR Stern RH Sedman AJ | 2000 | Eur J Drug Metab Pharmacokinet2000，25，2： | 1 |
| 16 | Pharmacodyna-mic effects and pharmacokinetics of atorvastatin after adminis-tration to normocholesterolemic subjects in the morning andevening 显示文摘 | Cilla Jr DD Gibson DM Whitfield LR | 1996 | Clin Pharmacol1996，36，7： | 1 |
| 17 | Atorvastatintransport in the Caco-2 cell model:contributions of P-glycoprotein and the protonmonocarboxylic acid co-transporter 显示文摘 | WU XC WHITFIELD LR STEWART BH | 2000 | Pharm Res2000，17，2： | 1 |
| 18 | Atorvastatin transport in the Caco-2 cell model显示文摘 | whitfield LR Stewart BH | 2000 | contributions of p-glycoprotein and proton-monocarboxylic acid co-transporter Pharm Res2000，17，4： | 1 |
| 19 | Multiple-dose pharmaco-kinetic, pharmacodynamics, andsafety of atorvastatin, an inhibitor ofHMG-CoA reductase, in healthy sub-jects 显示文摘 | Cilla DD Jr Whitfield LR GibsonDM | 1996 | Clini Pharmacol Ther1996，60，6： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员